Address

Molecular Medicine
Department of Medical Sciences
Entrance 70, 3rd floor
Research dept. II
University Hospital
SE-751 85 UPPSALA

See About us/Personnel for additional contact information

 

The Research Group in Molecular Medicine

  The research group in Molecular Medicine headed by Professor Ann-Christine Syvänen was started in 1998. Since the start we have been located at the Research Department of Uppsala University Hospital.
 

  Our research group studies human diseases using modern methods for genomics and epigenetics. We develop novel methods for genome analysis, establish these methods at the department, and apply them to medical or biological problems within the group and together with clinical collaborators. Our core technology is “minisequencing” primer extension pioneered by us.
 

  The research group in Molecular Medicine has seventeen members working with research projects in human genetics and technology development. Our research group is a partner in the European research projects: Cardiogenics, ENGAGE, Procardis, Geuvadis and ESGI (European Sequencing and Genotyping Infrastructure). The results of our work have been published as original articles in international journals and we have written review articles, PhD theses and book chapters related to our work.
 

 

  We co-organize and teach courses in Molecular Medicine and genotyping and sequencing technology targeted at students of different levels.

 

 

Ten favorite publications from the Molecular Medicine group:

  • Nordlund et al. (2011) Digital gene expression profiling of primary acute lymphoblastic leukemia cellsLeukemia. 2011 Dec 16 (Online)
  • Milani L, et al. (2010) DNA methylation for subtype classification and prediction of treatment outcome in patients with childhood acute lymphoblastic leukemia. Blood, 115(6), 1214-1225
  • Gateva et al. (2009) A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet, 41(11), 1228-1233
  • Milani L, et al. (2009) Allele-specific gene expression patterns in primary leukemic cells reveal regulation of gene expression by CpG site methylation. Genome Res, 19(1), 1-11
  • Chen et al. (2008) High-resolution, high-throughput SNP mapping in Drosophila melanogaster.Nat Methods, 5(4):323-329 
  • Hom et al. (2008) Association of Systemic Lupus Erythematosus with C8orf13–BLK and ITGAM–ITGAX.N Engl J Med, 358(9):900-909 
  • Syvänen (2005) Toward genome-wide SNP genotyping. Nat Genet, 37 S5-10
  • Sigurdsson et al. (2005) Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am J Hum Genet, 76:528-537
  • Lovmar et al. (2003) Quantitative evaluation by minisequencing and microarrays reveals accurate multiplexed SNP genotyping of whole genome amplified DNA. Nucleic Acids Res, 31:e129d
  • Syvänen (2001) Accessing genetic variation: Genotyping single nucleotide polymorphismsNat Rev Genet, 2:930-942

 

   SSF logo      CF logo

        EU logo              BCF logo     

 

 

         

News

  • MolMed receives new grant

    2012-04-23

    Large grant for epigenetic and genomic analyses of the brain from VR, FAS, Formas and Vinnova to Molecular Medicine and the SNP&SEQ platform.

  • New sequencer, MiSeq

    2012-03-16

    The SNP&SEQ Technology Platform has installed a MiSeq instrument from Illumina.

  • The Swedish Childhood Cancer Foundation

    2011-12-14

    Molecular Medicine research group has received funding from the Swedish Childhood Cancer Foundation.

  • VR grant

    2011-11-17

    VR-RFI has granted 6.7 million SEK for running costs to the SNP&SEQ platform.

  • K&A Wallenberg grant

    2011-10-04

    Molecular Medicine research group has received funding from the K&A Wallenberg foundation.

  • Publication in Nature

    2011-08-11

    A study that doubles the number of susceptibility genes for multiple sclerosis (MS) was published in Nature on Aug 11.

  • Instrument Upgrade.

    2011-06-20

    The SNP&SEQ Technology Platform have now upgraded our Genome Analyzer IIx with a HiSeq 2000 instrument from Illumina.

  • Publication in Nature Genetics

    2011-03-06

    Five new loci for coronary artery disease were published on-line in Nature Genetics on March 6th.

  • European Project: ESGI

    2011-01-18

    The Molecular Medicine group contributes to the ESGI infra-structure by technology development, eg. allele-specific gene expression and epigenetics.